October 4, 2024
TOPLINE: Older adults who experience falls are at a higher risk of developing dementia within a year. The study found that 10.6% of patients who fell […]
October 4, 2024
LONDON (Reuters) -British lawmakers will soon consider whether to give terminally ill adults a choice to end their own lives with medical assistance, after what proponents […]
October 4, 2024
WASHINGTON — Reduced doses of radiation therapy and immunotherapy did not work as well as the standard chemoradiation for early-stage HPV-associated oropharyngeal cancer, in a new […]
October 4, 2024
TOPLINE: Long-term exposure to air pollution, particularly particulate matter between 2.5 and 10 μm in diameter (PM10-2.5), is associated with a higher risk of developing physical […]
October 3, 2024
(Reuters) -The World Health Organization authorized Abbott Laboratories’ mpox diagnostic test for emergency use on Thursday, the first such approval in the agency’s effort to bolster […]
October 3, 2024
The US Food and Drug Administration (FDA) has expanded the approval of nivolumab (Opdivo, Bristol Myers Squibb) for the treatment of certain patients with resectable non–small […]
October 3, 2024
BARCELONA — Intravenous patient-controlled administration of hydromorphone offers better pain control and higher patient satisfaction compared with conventional oral morphine in managing severe cancer pain, according […]
October 3, 2024
BARCELONA, Spain — Ethnic Chinese immigrants affected by cancer are a particularly vulnerable group and may face significant barriers to receiving proper diagnosis and treatment, according […]
October 3, 2024
WASHINGTON — Timing matters when it comes to combining immunotherapy with chemoradiation in limited-stage small cell lung cancer (SCLC), according to the phase 3 NRG-LU005 trial […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482
Next page